Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells

par Proietti, Cecilia, Salatino, Mariana, Rosemblit, Cinthia, Carnevale, Romina, Pecci, Adalí, Kornblihtt, Alberto R., Molinolo, Alfredo A., Frahm, Isabel, Charreau, Eduardo H., Schillaci, Roxana, Elizalde, Patricia V.
Publié 2005

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer

par Schillaci, Roxana, Guzmán, Pablo, Cayrol, Florencia, Beguelin, Wendy, Díaz Flaqué, María C, Proietti, Cecilia J, Pineda, Viviana, Palazzi, Jorge, Frahm, Isabel, Charreau, Eduardo H, Maronna, Esteban, Roa, Juan C, Elizalde, Patricia V
Publié 2012

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

par Mercogliano, María F., Inurrigarro, Gloria, De Martino, Mara, Venturutti, Leandro, Rivas, Martín A., Cordo-Russo, Rosalía, Proietti, Cecilia J., Fernández, Elmer A., Frahm, Isabel, Barchuk, Sabrina, Allemand, Daniel H., Figurelli, Silvina, Deza, Ernesto Gil, Ares, Sandra, Gercovich, Felipe G., Cortese, Eduardo, Amasino, Matías, Guzmán, Pablo, Roa, Juan C., Elizalde, Patricia V., Schillaci, Roxana
Publié dans BMC Cancer (2017)

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

par Weinberg, Ruth S, Grecco, Marcelo O, Ferro, Gimena S, Seigelshifer, Debora J, Perroni, Nancy V, Terrier, Francisco J, Sánchez-Luceros, Analía, Maronna, Esteban, Sánchez-Marull, Ricardo, Frahm, Isabel, Guthmann, Marcelo D, Di Leo, Daniela, Spitzer, Eduardo, Ciccia, Graciela N, Garona, Juan, Pifano, Marina, Torbidoni, Ana V, Gomez, Daniel E, Ripoll, Giselle V, Gomez, Roberto E, Demarco, Ignacio A, Alonso, Daniel F
Publié dans Springerplus (2015)